The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes of advanced small cell lung cancer patients (SCLC pts) on phase I (Ph I) trials in the Drug Development Unit (DDU) at the Royal Marsden Hospital (RMH).
 
Samuel John Harris
No Relationships to Disclose
 
Brent O'Carrigan
No Relationships to Disclose
 
Juanita Suzanne Lopez
No Relationships to Disclose
 
Jaishree Bhosle
No Relationships to Disclose
 
Udai Banerji
No Relationships to Disclose
 
Sanjay Popat
Honoraria - Lilly
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD
 
Johann S. De Bono
Honoraria - Astellas Pharma; AstraZeneca; Genentech/Roche; Pfizer; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Genentech/Roche; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); PARP inhibitors and DNA repair defects (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Genmab; GlaxoSmithKline; Orion; Qiagen; Sanofi; Taiho Pharmaceutical; Vertex
 
Mary E.R. O'Brien
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; MSD Oncology; Pierre Fabre
 
Timothy Anthony Yap
Consulting or Advisory Role - Pfizer
Research Funding - AstraZeneca; Clearbridge Biomedics; Vertex
Travel, Accommodations, Expenses - Janssen-Cilag; MSD Oncology; Vertex